MIR339 Gene

HGNC Family Non-coding RNAs
Name microRNA 339
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMiR‐339 (predominantly the 5p strand, with evidence also for its 3p form) has emerged as a multifaceted regulator in both neurodegenerative and immunomodulatory contexts. In Alzheimer’s disease, reduced miR‐339‐5p levels lead to de‐repression of key targets such as BACE1, thereby promoting amyloid‐β peptide production and plaque formation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In parallel, disruption of microRNA processing that downregulates miR‐339 is associated with elevated ICAM‐1 expression in tumor cells, influencing immune surveillance."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": " Moreover, exosome‐derived miR‐339‐5p serves as a promising marker of radiosensitivity in esophageal cancer cells."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn various cancers, miR‐339‐5p acts largely as a tumor suppressor by targeting critical oncogenic regulators. It directly suppresses MDM2, thereby potentiating p53 function in cancer cells"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "4"}]}, {"type": "t", "text": "and is similarly effective in colorectal cancer where its downregulation correlates with impaired p53 responses."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " Its tumor‐suppressive capacity is further modulated by non‐coding RNAs: for example, in breast cancer, MALAT1 sponges miR‐339‐5p to affect downstream cellular responses"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": ", while MAFG‐AS1 similarly sequesters miR‐339‐5p in non‐small cell lung cancer to deregulate targets such as MMP15 that are critical for migration and invasion."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": " In gastric cancer, miR‐339 suppresses cell migration and proliferation through inhibition of NOVA1"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "8"}]}, {"type": "t", "text": ", and in colon cancer, its targeting of DNMT3B results in re‐expression of tumor suppressor genes."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "9"}]}, {"type": "t", "text": " Additional studies in hepatocellular and ovarian carcinomas reveal that elevated miR‐339‐5p levels curb invasion and metastatic traits"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "10"}]}, {"type": "t", "text": ", while exploratory work in gastric cancer further underscores its complex role."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "12"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond classical tumor suppression, miR‐339‐5p is implicated in diverse disease‐ and context‐specific pathways. In hematologic malignancies driven by aberrant FGFR1 activation (as in stem cell leukemia/lymphoma models), miR‐339‐5p is upregulated and promotes cell survival by mitigating proapoptotic gene expression."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "13"}]}, {"type": "t", "text": " Its regulation by circular RNAs, such as circ_0001795 in osteogenic cells, modulates YAP1 expression and thereby influences bone differentiation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "14"}]}, {"type": "t", "text": " In lung cancer, miR‐339 directly targets oncogenes including Skp2 and phosphatases like PRL‐1 to enhance the efficacy of radiotherapy"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "15"}]}, {"type": "t", "text": ", with its elevated serum levels also offering promise as a non‐invasive diagnostic biomarker."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "17"}]}, {"type": "t", "text": " Preliminary studies extend its functional reach into cardiovascular disease, where miR‐339 may influence coronary heart disease pathogenesis"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "18"}]}, {"type": "t", "text": ", and into disorders affecting endothelial progenitor cells in polycystic ovary syndrome."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "19"}]}, {"type": "t", "text": " In prostate cancer, deregulation of the circ_0005221/miR‐339‐5p/STAT5a axis has been linked to disease progression"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "20"}]}, {"type": "t", "text": ", while in glioma, miR‐339‐5p exerts inhibitory effects via the PTP4A1/HMGB1 pathway."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "21"}]}, {"type": "t", "text": " Its downregulation in schizophrenia appears to contribute to altered klotho gene expression and neuropsychiatric dysfunction"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "22"}]}, {"type": "t", "text": ", and in nasopharyngeal carcinoma, modulation of the miR‐339‐3p/KAT6A/TRIM24 axis affects epithelial–mesenchymal transition."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "23"}]}, {"type": "t", "text": " Finally, in acute myeloid leukemia, miR‐339‐5p acts as an antiproliferative agent by targeting SOX4"}, {"type": "fg", "children": [{"type": "fg_f", "ref": "24"}]}, {"type": "t", "text": ", while its targeting of Skp2 also contributes to growth inhibition in lung cancer.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Justin M Long, Balmiki Ray, Debomoy K Lahiri "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-339-5p down-regulates protein expression of β-site amyloid precursor protein-cleaving enzyme 1 (BACE1) in human primary brain cultures and is reduced in brain tissue specimens of Alzheimer disease subjects."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.518241"}], "href": "https://doi.org/10.1074/jbc.M113.518241"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24352696"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24352696"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Ryo Ueda, Gary Kohanbash, Kotaro Sasaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0811817106"}], "href": "https://doi.org/10.1073/pnas.0811817106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19520829"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19520829"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Aiping Luo, Xuantong Zhou, Xing Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosome-derived miR-339-5p mediates radiosensitivity by targeting Cdc25A in locally advanced esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41388-019-0771-0"}], "href": "https://doi.org/10.1038/s41388-019-0771-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30858545"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30858545"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "M D Jansson, N D Damas, M Lees, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-339-5p regulates the p53 tumor-suppressor pathway by targeting MDM2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2014.130"}], "href": "https://doi.org/10.1038/onc.2014.130"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24882579"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24882579"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Cen Zhang, Juan Liu, Xiaolong Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.2379"}], "href": "https://doi.org/10.18632/oncotarget.2379"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25193859"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25193859"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Liuhong Zheng, Yuhan Zhang, Yajun Fu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA MALAT1 regulates BLCAP mRNA expression through binding to miR-339-5p and promotes poor prognosis in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biosci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/BSR20181284"}], "href": "https://doi.org/10.1042/BSR20181284"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30683807"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30683807"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "You Chao Jia, Jian Yi Wang, Yu Ying Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA MAFG-AS1 facilitates the migration and invasion of NSCLC cell via sponging miR-339-5p from MMP15."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Biol Int (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/cbin.11092"}], "href": "https://doi.org/10.1002/cbin.11092"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30599080"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30599080"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Bo Shen, Yan Zhang, Shaorong Yu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-339, an epigenetic modulating target is involved in human gastric carcinogenesis through targeting NOVA1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2015.09.009"}], "href": "https://doi.org/10.1016/j.febslet.2015.09.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26391641"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26391641"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Ali Afgar, Pezhman Fard-Esfahani, Amirhosein Mehrtash, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Ther (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384047.2016.1235657"}], "href": "https://doi.org/10.1080/15384047.2016.1235657"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27668319"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27668319"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Yi-Lin Wang, Chi-mei Chen, Xiao-Ming Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Res Hepatol Gastroenterol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.clinre.2015.05.022"}], "href": "https://doi.org/10.1016/j.clinre.2015.05.022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26186881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26186881"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Weiwei Shan, Jun Li, Yang Bai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-339-5p inhibits migration and invasion in ovarian cancer cell lines by targeting NACC1 and BCL6."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s13277-015-4390-2"}], "href": "https://doi.org/10.1007/s13277-015-4390-2"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26553360"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26553360"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Chenchen Wang, Yakai Huang, Jieyun Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiRNA-339-5p suppresses the malignant development of gastric cancer via targeting ALKBH1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Exp Mol Pathol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.yexmp.2020.104449"}], "href": "https://doi.org/10.1016/j.yexmp.2020.104449"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32380054"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32380054"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Tianxiang Hu, Yating Chong, Sumin Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-339 Promotes Development of Stem Cell Leukemia/Lymphoma Syndrome via Downregulation of the "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "BCL2L11"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " and "}, {"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "BAX"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " Proapoptotic Genes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-17-4049"}], "href": "https://doi.org/10.1158/0008-5472.CAN-17-4049"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29735550"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29735550"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Mingyi Li, Chenxia Li, Huarong Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircRNA_0001795 sponges miRNA-339-5p to regulate yes-associated protein 1 expression and attenuate osteoporosis progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Bioengineered (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/21655979.2021.2022074"}], "href": "https://doi.org/10.1080/21655979.2021.2022074"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35040370"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35040370"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Hong Ren, Yueqiao Zhang, Hongzhou Zhu "}, {"type": "b", "children": [{"type": "t", "text": "MiR-339 depresses cell proliferation via directly targeting S-phase kinase-associated protein 2 mRNA in lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Thorac Cancer (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/1759-7714.12597"}], "href": "https://doi.org/10.1111/1759-7714.12597"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29377618"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29377618"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Jia Wang, Mawei Jiang, Shian Xia "}, {"type": "b", "children": [{"type": "t", "text": "miR-339-5p Increases Radiosensitivity of Lung Cancer Cells by Targeting Phosphatases of Regenerating Liver-1 (PRL-1)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Sci Monit (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.12659/MSM.910808"}], "href": "https://doi.org/10.12659/MSM.910808"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30462625"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30462625"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Keson Trakunram, Pichitpon Chaniad, Sarayut Lucien Geater, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biol Med (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.20892/j.issn.2095-3941.2020.0063"}], "href": "https://doi.org/10.20892/j.issn.2095-3941.2020.0063"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32944397"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32944397"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Linying Shi, Yuan Zhang, Jing Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-339 is a potential biomarker of coronary heart disease to aggravate oxidative stress through Nrf2/FOXO3 targeting Sirt2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Palliat Med (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.21037/apm-20-603"}], "href": "https://doi.org/10.21037/apm-20-603"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33849089"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33849089"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jie Zhang, Wangming Xu, Saijiao Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The role of miRNA-339-5p in the function of vascular endothelial progenitor cells in patients with PCOS."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Reprod Biomed Online (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.rbmo.2021.09.017"}], "href": "https://doi.org/10.1016/j.rbmo.2021.09.017"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35151575"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35151575"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Sai-Sai Chen, Yu-Wei Zhang, Ya-Li Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "[Hsa_circ_0005221 promotes prostate cancer progression through the miR-339-5p/STAT5a pathway]."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Zhonghua Nan Ke Xue (2021)"}]}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34914211"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34914211"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Buyi Zheng, Shouyi Wang, Huanan Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Inhibitory Effect of miR-339-5p on Glioma through PTP4A1/HMGB1 Pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Dis Markers (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1155/2022/2231195"}], "href": "https://doi.org/10.1155/2022/2231195"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35872698"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35872698"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Amandeep Birdi, Pvsn Kiran Kumar, Naresh Nebhinani, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Association of circulatory Klotho levels and its expression with miRNA- 339 in patients with schizophrenia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Behav Brain Res (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbr.2023.114359"}], "href": "https://doi.org/10.1016/j.bbr.2023.114359"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36842554"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36842554"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Pei Gao, Kun Zhao, Wuhao Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-339-3p inhibits cell growth and epithelial-mesenchymal transition in nasopharyngeal carcinoma by modulating the KAT6A/TRIM24 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Clin Oncol (2022)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10147-022-02231-8"}], "href": "https://doi.org/10.1007/s10147-022-02231-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "35976474"}], "href": "https://pubmed.ncbi.nlm.nih.gov/35976474"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Melanie Gartz, Margaret Beatka, Mariah J Prom, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cardiomyocyte-produced miR-339-5p mediates pathology in Duchenne muscular dystrophy cardiomyopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hum Mol Genet (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/hmg/ddab199"}], "href": "https://doi.org/10.1093/hmg/ddab199"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "34270708"}], "href": "https://pubmed.ncbi.nlm.nih.gov/34270708"}]}]}]}
Synonyms MIR-339, HSA-MIR-339, MIRN339
NCBI Gene ID 442907
API
Download Associations
Predicted Functions View MIR339's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR339's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR339's ARCHS4 Predicted Functions.

Functional Associations

MIR339 has 582 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 21 datasets.

Click the + buttons to view associations for MIR339 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR339 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR339 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR339 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR339 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR339 gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR339 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR339 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR339 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
ESCAPE Omics Signatures of Genes and Proteins for Stem Cells PubMedIDs of publications reporting gene signatures containing MIR339 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR339 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR339 from the GeneSigDB Published Gene Signatures dataset.
GEO Signatures of Differentially Expressed Genes for Gene Perturbations gene perturbations changing expression of MIR339 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset.
GEO Signatures of Differentially Expressed Genes for Small Molecules small molecule perturbations changing expression of MIR339 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset.
GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations transcription factor perturbations changing expression of MIR339 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset.
GTEx Tissue Gene Expression Profiles tissues with high or low expression of MIR339 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with MIR339 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR339 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR339 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
KnockTF Gene Expression Profiles with Transcription Factor Perturbations transcription factor perturbations changing expression of MIR339 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR339 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR339 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.